Literature DB >> 11843055

Colonic production of nitric oxide gas in ulcerative colitis, collagenous colitis and uninflamed bowel.

A Perner1, I Nordgaard, P Matzen, J Rask-Madsen.   

Abstract

BACKGROUND: Nitric oxide (NO) produced in excess by the inflamed human colon is generally considered a pathway of mucosal damage. In an attempt to quantify colonic mucosal production of NO in various forms of colitis we performed 'steady-state' gas perfusion of whole colon in 11 patients with ulcerative colitis, 10 patients with collagenous colitis and 20 controls with uninflamed mucosa.
METHODS: The tip of a Teflon tube was placed in the caecum during colonoscopy. Subsequently, argon was infused at a constant rate for 70-180 min. Argon and NO in gas sampled from the rectum were measured by neutron activation analysis and the chemiluminescence technique, respectively.
RESULTS: The use of argon as a marker of colonic NO output was justified by complete recovery (96%+/-2; mean +/- s(x); n = 5) of argon in gas collected from the rectum and a constant output of NO at varying perfusion rates (25, 50 and 75 ml/min coefficient of variation 21%; n = 6). In patients with ulcerative colitis, colonic output of NO was 10-fold higher (P < 0.001) than in controls and positively correlated (P < 0.01) to indices of disease activity. In patients with collagenous colitis, colonic output of NO was 50-fold higher (P < 0.01) than in controls during periods with watery diarrhoea (n = 6), but within the range observed in ulcerative colitis in the absence of diarrhoea (n = 4).
CONCLUSIONS: Argon gas perfusion of whole colon using chemiluminescence technique for measurement of NO is a reliable method for quantification of colonic mucosal NO production. Increased colonic production of NO in collagenous colitis, which exceeds the output observed even in extensive ulcerative colitis, militates against the theory that NO per se is a cause of mucosal injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843055     DOI: 10.1080/003655202753416858

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.

Authors:  Runjan Chetty; Dhirendra Govender
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile.

Authors:  Peter P Tagkalidis; Peter R Gibson; Prithi S Bhathal
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

3.  Expression Profiling of Inflammatory and Immunological Genes in Collagenous Colitis.

Authors:  Qingqing Liu; Noam Harpaz
Journal:  J Crohns Colitis       Date:  2019-05-27       Impact factor: 9.071

4.  Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice.

Authors:  Bruce A Vallance; Wanyin Deng; Myriam De Grado; Crystal Chan; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

Authors:  L Andresen; V L Jørgensen; A Perner; A Hansen; J Eugen-Olsen; J Rask-Madsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 6.  Diagnosis and management of microscopic colitis.

Authors:  Curt Tysk; Johan Bohr; Nils Nyhlin; Anna Wickbom; Sune Eriksson
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

7.  Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis.

Authors:  Anders Enocksson; Jon Lundberg; Eddie Weitzberg; Anna Norrby-Teglund; Bo Svenungsson
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

8.  Evolution of collagenous colitis into severe and extensive ulcerative colitis.

Authors:  Hugh J Freeman; Ken W Berean; Michael Nimmo
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

9.  Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases.

Authors:  Golshid Jahanshahi; Vian Motavasel; Ali Rezaie; Ali A Hashtroudi; Naser E Daryani; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.487

Review 10.  Recent advances in diagnosis and treatment of microscopic colitis.

Authors:  Curt Tysk; Anna Wickbom; Nils Nyhlin; Sune Eriksson; Johan Bohr
Journal:  Ann Gastroenterol       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.